SANTA ANA, Calif.—Advanced Medical Optics (NYSE: EYE) posted net income of $22 million in the second quarter, compared with a $166.8 million net loss in 2007’s Q2 that was caused by a worldwide recall of the company’s Complete MoisturePlus Multi-Purpose contact lens solution in May of last year.

In this year’s second quarter, Advanced Medical Optics’ consolidated sales rose 22.6 percent (up 15.4 percent at constant currency rates) to $320.5 million. That total included a 14.9 percent increase in cataract sales, to $144.5 million; a 1.5 percent increase in refractive sales, to $118.3 million; and a 202.8 percent jump in sales of eyecare products, to $57.6 million.

In this year’s first six months, the company had net income of $28.9 million, compared to a $154.7 million net loss in 2007’s first half. Total sales in 2008’s first six months reached $624.3 million, vs. $513.1 million the prior year.

Advanced Medical Optics’ Q2 results “showed the strength and resiliency of our global business, despite the declines in domestic refractive volumes brought on by the weakening U.S. economy,” said Jim Mazzo, chairman and chief executive officer. “The value and benefit of expanding our refractive business internationally came into focus as strong refractive sales outside the U.S. helped to partially offset domestic challenges.”